Special Report: Will the COVID-19 Recovery Be Bumpier than Expected?
Though IVD and commercial lab Q3 2023 earnings reports held promising signs, Q4 2024 and FY2023 results tell a different story.
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
Though IVD and commercial lab Q3 2023 earnings reports held promising signs, Q4 2024 and FY2023 results tell a different story.
From - Laboratory Industry Report
The Targeted Agent and Profiling Utilization Registry (TAPUR) study began recruiting its first patients last month. The trial, the first clinical trial undertaken by …
From - Laboratory Industry Report
Gone are the days of isolated entities and closed systems within the American healthcare industry. And as once discrete services come to extend across the…
From - Laboratory Industry Report
LabCorp has purchased the outreach laboratory business of a Los Angeles-area community hospital. Henry Mayo Newhall Hospital announced…
From - Laboratory Industry Report
Theranos, which continues to come under fire regarding the viability of its testing platform, has just named an eight-member scientific and advisory medical board that contains luminaries from…